Circulating CYFRA 21-1 is a Specific Diagnostic and Prognostic Biomarker in Biliary Tract Cancer (Q35654552)

9 August 2017

title

Circulating CYFRA 21-1 is a Specific Diagnostic and Prognostic Biomarker in Biliary Tract Cancer (English)

1 reference

9 August 2017

0 references

Michael H Chapman

1

1 reference

9 August 2017

Neomal S Sandanayake

2

1 reference

9 August 2017

Fausto Andreola

3

1 reference

9 August 2017

Dipok K Dhar

4

1 reference

9 August 2017

George J Webster

5

1 reference

9 August 2017

James S Dooley

6

1 reference

9 August 2017

Stephen P Pereira

7

1 reference

9 August 2017

publication date

1 June 2011

1 reference

Journal of clinical and experimental hepatology

9 August 2017

published in

1 reference

9 August 2017

volume

1

1 reference

9 August 2017

issue

1

1 reference

9 August 2017

page(s)

6-12

1 reference

Detection of circulating tumour cells in peripheral blood with an automated scanning fluorescence microscope

9 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3252025

Detection of circulating cancer cells in lung cancer patients with a panel of marker genes

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3252025

Isolation of rare circulating tumour cells in cancer patients by microchip technology

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3252025

The value of serum CA 19-9 in predicting cholangiocarcinomas in patients with primary sclerosing cholangitis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3252025

Serum CYFRA 21-1 (cytokeratin-19 fragments) is a useful tumour marker for detecting disease relapse and assessing treatment efficacy in breast cancer

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3252025

CYFRA 21-1 is a prognostic determinant in non-small-cell lung cancer: results of a meta-analysis in 2063 patients

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3252025

Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3252025

Hepatic and extrahepatic malignancies in primary sclerosing cholangitis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3252025

Elevated tumour marker CA19-9: clinical interpretation and influence of obstructive jaundice

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3252025

The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3252025

Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3252025

12 July 2018

Biliary tract cancers.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3252025

Intrahepatic cholangiocarcinoma with increased serum CYFRA 21-1 level

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3252025

Clinical significance of serum CYFRA 21-1 in gastric cancer

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3252025

"Natural history" of unresected cholangiocarcinoma: patient outcome after noncurative intervention

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3252025

Measurement of cytokeratin 19 fragments as a marker of lung cancer by CYFRA 21-1 enzyme immunoassay

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3252025

Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3252025

Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3252025

Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3252025

Diagnostic and prognostic value of Cyfra 21-1 compared with other tumour markers in patients with non-small cell lung cancer: a prospective study of 116 patients

25 September 2018

1 reference

12 December 2020

Cholangioscopic characterization of dominant bile duct stenoses in patients with primary sclerosing cholangitis

1 reference

12 December 2020

Serum cytokeratin 19 fragment (CYFRA21-1) as a prognostic factor in intrahepatic cholangiocarcinoma

1 reference

12 December 2020

The expression of cytokeratins 7, 19, and 20 in primary and metastatic carcinomas of the liver

1 reference

12 December 2020

Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma

1 reference

12 December 2020

Serum CYFRA 21-1 in patients with invasive bladder cancer and its relevance as a tumor marker during chemotherapy

1 reference

12 December 2020

CA19-9 does not predict cholangiocarcinoma in patients with primary sclerosing cholangitis undergoing liver transplantation

1 reference

12 December 2020

Advances in the diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis

1 reference

12 December 2020

Diagnosis of biliary strictures in conjunction with endoscopic retrograde cholangiopancreaticography, with special reference to patients with primary sclerosing cholangitis

1 reference

12 December 2020

Diagnostic and Prognostic Value of Cyfra 21-1 Compared with Other Tumour Markers in Patients with Non-small Cell Lung Cancer: A Prospective Study of 116 Patients

1 reference

Crossref

https://api.crossref.org/works/10.1016%2FS0973-6883%2811%2960110-2

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1016/S0973-6883(11)60110-2

1 reference

9 August 2017

1 reference

9 August 2017

1 reference